Tags » LXX

NetworkNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Transforms Drug Delivery Methods

Related Editorial
Most people who try to quit smoking cigarettes will fail. Why? Scientific research shows that the overwhelming culprit is nicotine. Nicotine holds such an addictive power over smokers, because it arrives in the brain so quickly — smoking delivers nicotine even faster than an injection, one researcher notes ( 534 more words

NetworkNewsWire Release

At Last... A Reader's Edition of the Septuagint

Septuagint readers have wanted this resource for a LOOONG time, and now thanks to William A. Ross and Gregory R. Lanier, we only have to wait till November for… 155 more words

Bible

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Definitive License Agreement with GP Holdings LLC.

Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has entered a definitive technology licensing agreement with California cannabis beverage manufacturer GP Holdings LLC. 472 more words

NetworkNewsWire Release

Innovative Cannabis Delivery Technology Boosts Discovery, Momentum in Biotech Sectors

NetworkNewsWire Editorial Coverage: Most people who try to quit smoking cigarettes will fail. Why? Scientific research shows that the overwhelming culprit is nicotine. Nicotine holds such an addictive power over smokers, because it arrives in the brain so quickly — smoking delivers nicotine even faster than an injection, one researcher notes ( 2,311 more words

NetworkNewsWire Release

Innovative Cannabis Delivery Technology Boosts Discovery, Momentum in Biotech Sectors

NetworkNewsWire Editorial Coverage: Most people who try to quit smoking cigarettes will fail. Why? Scientific research shows that the overwhelming culprit is nicotine. Nicotine holds such an addictive power over smokers, because it arrives in the brain so quickly — smoking delivers nicotine even faster than an injection, one researcher notes ( 2,311 more words

NetworkNewsWire Release

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Begins Human Clinical Study of Its High Absorption TurboCBD Capsules

  • Study will measure the cardiovascular and cognitive health effects of patented DehydraTECH, its disruptive delivery technology
  • Data generated will help company’s development of next-generation cannabinoid product formulations…
  • 512 more words
NetworkNewsWire Release

Innovative Cannabis Delivery Technology Boosts Discovery, Momentum in Biotech Sectors

NetworkNewsWire Editorial Coverage: Most people who try to quit smoking cigarettes will fail. Why? Scientific research shows that the overwhelming culprit is nicotine. Nicotine holds such an addictive power over smokers, because it arrives in the brain so quickly — smoking delivers nicotine even faster than an injection, one researcher notes ( 2,311 more words

NetworkNewsWire Release